ISSAQUAH, Wash., March 30, 2022 (Newswire.com) - Olympic Ophthalmics announced today that the U.S. Food and Drug Administration (FDA) has granted its 510(K) request for its second-generation iTEAR100 device, a prescription neuromodulation therapy to acutely increase tear production in adult ...